Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393560 · ClinicalTrials.gov registry record
DECT Study in Allopurinol-Treated Gout Patients
A clinical trial, sponsored by Ardea Biosciences.
- Completed
- Registry status
- 223
- Enrollment target
NCT02393560: Completed study, sponsored by Ardea Biosciences.
NCT02393560 is a clinical trial that has completed, run by Ardea Biosciences. The registered enrollment target is 223 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02393560 has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- 223 participants
- Enrollment target
Study Summary
The purpose of this study is to determine presence and volume of monosodium urate (MSU) crystal deposits as determined by dual-energy computed tomography (DECT) imaging in gout subjects treated with allopurinol with and without visible tophi.
Interventions
- PROCEDURE DECT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-10 |
What the finished NCT02393560 record still lists
NCT02393560 is an observational study that tracks outcomes without assigning an intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which DECT scan is the first listed.
NCT02393560 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02393560 about?
NCT02393560 is a clinical study titled "DECT Study in Allopurinol-Treated Gout Patients". The purpose of this study is to determine presence and volume of monosodium urate (MSU) crystal deposits as determined by dual-energy computed tomography (DECT) imaging in gout subjects treated with allopurinol with and without visible tophi.
What is the current status of trial NCT02393560?
This trial is currently completed. The enrollment target is 223 participants. The study started on 2015-04. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02393560?
The interventions under investigation include: DECT scan (PROCEDURE).
Who is sponsoring clinical trial NCT02393560?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia